We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.41B
AUM Growth
+$140M
Cap. Flow
+$151M
Cap. Flow %
10.75%
Top 10 Hldgs %
8.08%
Holding
2,051
New
446
Increased
504
Reduced
559
Closed
528

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$6.69M
2
C icon
Citigroup
C
+$6.01M
3
TRIP icon
TripAdvisor
TRIP
+$5.94M
4
VPHM
VIROPHARMA INC
VPHM
+$5.33M
5
WELL icon
Welltower
WELL
+$5.33M

Sector Composition

Rank Sector Weight
1 Healthcare 15.61%
2 Technology 11.5%
3 Industrials 10.6%
4 Consumer Discretionary 10.6%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLX icon
276
Clorox
CLX
$12.4B
$1.14M 0.08%
12,946
+9,190
+245% +$807K
SRCL
277
DELISTED
Stericycle Inc
SRCL
$1.13M 0.08%
9,962
+1,798
+22% +$208K
IEX icon
278
IDEX
IEX
$17.4B
$1.13M 0.08%
15,497
+3,154
+26% +$230K
TIBX
279
DELISTED
TIBCO SOFTWARE INC
TIBX
$1.13M 0.08%
55,500
+44,368
+399% +$963K
STRZA
280
DELISTED
Starz - Series A
STRZA
$1.12M 0.08%
34,768
-15,275
-31% -$464K
CHK
281
DELISTED
Chesapeake Energy Corporation
CHK
$1.12M 0.08%
231
-66
-22% -$322K
GIS icon
282
General Mills
GIS
$19.3B
$1.12M 0.08%
21,541
-20,889
-49% -$1.03M
NTLS
283
DELISTED
NTELOS HLDGS CORP COM
NTLS
$1.12M 0.08%
82,660
+12,900
+18% +$210K
PDLI
284
DELISTED
PDL BioPharma, Inc.
PDLI
$1.11M 0.08%
134,072
+15,784
+13% +$135K
TESS
285
DELISTED
Tessco Technologies Inc
TESS
$1.11M 0.08%
29,681
-6,232
-17% -$230K
SNPS icon
286
Synopsys
SNPS
$76.7B
$1.11M 0.08%
+28,835
New +$1.16M
MAN icon
287
ManpowerGroup
MAN
$2.5B
$1.11M 0.08%
14,036
-5,576
-28% -$441K
UIS icon
288
Unisys
UIS
$222M
$1.1M 0.08%
36,178
-12,319
-25% -$397K
XEL icon
289
Xcel Energy
XEL
$48.5B
$1.1M 0.08%
36,222
-12,226
-25% -$356K
ANF icon
290
Abercrombie & Fitch
ANF
$4.92B
$1.1M 0.08%
+28,478
New +$1.04M
FLG
291
Flagstar Bank National Association
FLG
$6.01B
$1.09M 0.08%
22,713
+2,849
+14% +$139K
CFN
292
DELISTED
CAREFUSION CORPORATION
CFN
$1.08M 0.08%
26,950
+17,586
+188% +$711K
RGEN icon
293
Repligen
RGEN
$8.3B
$1.08M 0.08%
84,193
-20,700
-20% -$297K
TTC icon
294
Toro Company
TTC
$9.4B
$1.08M 0.08%
34,242
+6,468
+23% +$208K
APD icon
295
Air Products & Chemicals
APD
$65.8B
$1.07M 0.08%
9,750
-19,627
-67% -$2.08M
WLL
296
DELISTED
Whiting Petroleum Corporation
WLL
$1.07M 0.08%
51
-7
-12% -$133K
COO icon
297
Cooper Companies
COO
$14.5B
$1.06M 0.08%
30,956
-27,104
-47% -$869K
IMKTA icon
298
Ingles Markets
IMKTA
$1.73B
$1.06M 0.08%
44,639
-2,363
-5% -$58.3K
ELV icon
299
Elevance Health
ELV
$82.2B
$1.06M 0.08%
10,668
+6,800
+176% +$615K
GPRE icon
300
Green Plains
GPRE
$1.2B
$1.06M 0.08%
35,427
+9,200
+35% +$226K

Similar funds

GSA Capital Partners's Q1 2014 Portfolio in Review

As of Q1 2014, GSA Capital Partners held 2,051 positions worth $1.41B, up 11% from $1.27B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

GSA Capital Partners deployed $151M of net new capital in Q1 2014, opening 446 new positions and adding to 504 existing holdings. Its largest new stake was Alphabet (Google) Class C: 527,450 shares worth $14.6M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Citigroup, an estimated $6.01M trimmed.

  • GSA Capital Partners's largest Q1 2014 buy was Alphabet (Google) Class C: 527,450 shares worth $14.6M.
  • GSA Capital Partners added most to Micron Technology in Q1 2014, an estimated $12.3M increase.
  • GSA Capital Partners's biggest Q1 2014 reduction was Citigroup, cutting an estimated $6.01M.
  • GSA Capital Partners fully exited Pfizer in Q1 2014, selling an estimated $6.69M.
  • GSA Capital Partners's ten largest holdings make up 8.1% of its $1.41B portfolio in Q1 2014.
  • GSA Capital Partners opened 446 new positions and closed 528 in Q1 2014.
  • GSA Capital Partners's portfolio value rose 11% quarter-over-quarter to $1.41B.

Based on GSA Capital Partners's 13F filing for Q1 2014, filed 14 May 2014.